Eric J Ende, Director at Matinas BioPharma, holds 208.90K shares in Avadel Pharmaceuticals (Ticker: AVDL), holds 144.09K shares in Matinas BioPharma (Ticker: MTNB), holds ― shares in Progenics (Ticker: PGNX). Most recently, Eric J Ende Bought ― shares of Avadel Pharmaceuticals on Jan 14, 2025 for an estimated value of 235.20K.
What is the percentage of profitable transactions made by Eric J Ende?
The percentage of profitable transactions made by Eric J Ende is 100%.
What is the average return per transaction made by Eric J Ende?
The average return per transaction made by Eric J Ende is 185.10%.
What stocks does Eric J Ende hold?
Eric J Ende holds: MTNB, AVDL, PGNX, NBSE stocks.
What was Eric J Ende’s latest transaction?
Eric J Ende latest transaction was an Informative Buy of $235.20K.
What was Eric J Ende's most profitable transaction?
Eric J Ende’s most profitable transaction was an Informative Buy of AVDL stock on May 31, 2022. The return on the trade was 526.60%.
What is Eric J Ende's role in Matinas BioPharma?
Eric J Ende's role in Matinas BioPharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.